Source: StreetInsider

Press Release: Atem Capital : /C O R R E C T I O N -- Deka Biosciences/

In the news release, Deka Biosciences Closes USD $20 Million Series B2 Financing Led by MPM BioImpact, issued 28-Sep-2023 by Deka Biosciences over PR Newswire, we...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Anton Gopka's photo - CEO of Atem Capital

CEO

Anton Gopka

CEO Approval Rating

85/100

Read more